PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
87.35%
Positive growth while CRK shows revenue decline. John Neff would investigate competitive advantages.
4.79%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
167.60%
Gross profit growth 1.25-1.5x CRK's 115.92%. Bruce Berkowitz would examine sustainability.
42.84%
Margin expansion below 50% of CRK's 116.42%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
-6.00%
G&A reduction while CRK shows 3.06% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-25.00%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-5.82%
Operating expenses reduction while CRK shows 65.29% growth. Joel Greenblatt would examine advantage.
-1.24%
Both companies reducing total costs. Martin Whitman would check industry trends.
0.71%
Interest expense growth while CRK reduces costs. John Neff would investigate differences.
-0.25%
D&A reduction while CRK shows 0.33% growth. Joel Greenblatt would examine efficiency.
358.30%
EBITDA growth exceeding 1.5x CRK's 7.86%. David Dodd would verify competitive advantages.
154.45%
EBITDA margin growth exceeding 1.5x CRK's 8.61%. David Dodd would verify competitive advantages.
626.67%
Operating income growth exceeding 1.5x CRK's 12.34%. David Dodd would verify competitive advantages.
381.12%
Operating margin growth exceeding 1.5x CRK's 9.56%. David Dodd would verify competitive advantages.
-27.73%
Other expenses reduction while CRK shows 2.39% growth. Joel Greenblatt would examine advantage.
225.26%
Pre-tax income growth exceeding 1.5x CRK's 16.06%. David Dodd would verify competitive advantages.
166.86%
Pre-tax margin growth exceeding 1.5x CRK's 13.40%. David Dodd would verify competitive advantages.
-667.44%
Tax expense reduction while CRK shows 6.25% growth. Joel Greenblatt would examine advantage.
269.37%
Net income growth below 50% of CRK's 577.84%. Michael Burry would check for structural issues.
190.41%
Net margin growth below 50% of CRK's 592.98%. Michael Burry would check for structural issues.
267.80%
EPS growth below 50% of CRK's 562.07%. Michael Burry would check for structural issues.
268.94%
Diluted EPS growth below 50% of CRK's 562.07%. Michael Burry would check for structural issues.
0.77%
Share count reduction below 50% of CRK's 0.05%. Michael Burry would check for concerns.
-0.01%
Diluted share reduction while CRK shows 0.05% change. Joel Greenblatt would examine strategy.